TriangleFOR PATIENTS · SOURCE READING
Key Points
Source: Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 16, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview for Transitional Cell Cancer of the Renal Pelvis and Ureter
There are different types of treatment for patients with transitional cell cancer of the renal pelvis and ureter.
The following type of treatment is used:
The following type of treatment is used:
Surgery
New types of treatment are being tested in clinical trials.
New types of treatment are being tested in clinical trials.
Fulguration
New types of treatment are being tested in clinical trials.
Segmental resection of the renal pelvis
Treatment for transitional cell cancer of the renal pelvis and ureter may cause side effects.
Follow-up care may be needed.
Preserved source evidence · Independent clinical review pending · Not medical advice